Evidence map›Paper›PMID 28261665›Full record

ArticleACS sensors2016

Toward the Responsible Development and Commercialization of Sensor Nanotechnologies.

Tarek R Fadel, Dorothy F Farrell, Lisa E Friedersdorf, Mark H Griep, Mark D Hoover, Michael A Meador, M Meyyappan

Abstract read
In one paragraph

Article in ACS sensors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Nanosensors for water quality monitoring.Nature nanotechnology · 2018
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tarek R Fadel *The National Nanotechnology Coordination Office, 4201 Wilson Boulevard, Suite 405, Arlington, Virginia 22230, United States.
Dorothy F Farrell *The National Cancer Institute, National Institutes of Health, 31 Center Drive, 10A52, Bethesda, Maryland 20892, United States.
Lisa E Friedersdorf *The National Nanotechnology Coordination Office, 4201 Wilson Boulevard, Suite 405, Arlington, Virginia 22230, United States.
Mark H Griep *The U.S. Army Research Laboratory, Aberdeen Proving Ground, Aberdeen, Maryland 21005, United States.
Mark D Hoover *The National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, West Virginia 26505, United States.
Michael A Meador *The National Nanotechnology Coordination Office, 4201 Wilson Boulevard, Suite 405, Arlington, Virginia 22230, United States.
M Meyyappan *Center for Nanotechnology, NASA Ames Research Center, Moffett Field, California 94035, United States.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Nanotechnology-enabled sensors (or nanosensors) will play an important role in enabling the progression toward ubiquitous information systems as the Internet of Things (IoT) emerges. Nanosensors offer new, miniaturized solutions in physiochemical and biological sensing that enable increased sensitivity, specificity, and multiplexing capability, all with the compelling economic drivers of low cost and high-energy efficiency. In the United States, Federal agencies participating in the National Nanotechnology Initiative (NNI) "Nanotechnology for Sensors and Sensors for Nanotechnology: Improving and Protecting Health, Safety, and the Environment" Nanotechnology Signature Initiative (the Sensors NSI), address both the opportunity of using nanotechnology to advance sensor development and the challenges of developing sensors to keep pace with the increasingly widespread use of engineered nanomaterials. This perspective article will introduce and provide background on the NNI signature initiative on sensors. Recent efforts by the Sensors NSI aimed at promoting the successful development and commercialization of nanosensors will be reviewed and examples of sensor nanotechnologies will be highlighted. Future directions and critical challenges for sensor development will also be discussed.

Indexed as

commercializationdata qualityengineered nanomaterialslife cyclenanosensors

Identifiers

PMID28261665
PMCPMC5332131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.